Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe

Funding Information: The INTEGRATE project received an unconditioned grant from Gilead Sciences Europe Ltd. This study was also funded by the Swedish Research Council (2016‐01675, to AS), the European Union by the CARE H2020 project (under grant agreement no. 825673) and Stockholm County Council (AL...

Full description

Bibliographic Details
Main Author: EuResist Network, INTEGRATE study group (author)
Other Authors: Abecasis, Ana (author), Gomes, Perpetua (author), Vandamme, A. M. (author)
Format: article
Language:eng
Published: 2022
Subjects:
dolutegravir
effectiveness
elvitegravir
HIV
INSTI
integrase strand transfer inhibitors
raltegravir
treatment-experienced
Health Policy
Infectious Diseases
Pharmacology (medical)
SDG 3 - Good Health and Well-being
Online Access:http://hdl.handle.net/10362/143388
Country:Portugal
Oai:oai:run.unl.pt:10362/143388

Internet

http://hdl.handle.net/10362/143388

Similar Items